Novel Compounds as LPAR1 Inhibitors for Treating Systemic Sclerosis

ACS Medicinal Chemistry Letters 2026 Open access

Read full text
Authors: Ram W. Sabnis
DOI: 10.1021/acsmedchemlett.5c00764
Cited by: 0
References: 3

Abstract

High Resolution Image Download MS PowerPoint Slide Provided herein are novel compounds as LPAR1 inhibitors, pharmaceutical compositions, use of such compounds in treating systemic sclerosis, and processes for preparing such compounds.

Fields of Study & Subjects

Systemic Sclerosis and Related Diseases Amyotrophic Lateral Sclerosis Research Protein Tyrosine Phosphatases

Publication details

Journal / source
ACS Medicinal Chemistry Letters
Publisher
American Chemical Society (ACS)
Volume
17
Issue
2
Pages
296–297
Publication date
2 January 2026
Language
EN